← FDA Drug Approvals (Drugs@FDA)

EXDENSUR

BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2025-12-16

Drug application

FDA Application #

BLA761458

Application type

Biologics License Application

Brand name

EXDENSUR

Generic name

DEPEMOKIMAB

Active ingredients

DEPEMOKIMAB-ULAA

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE LLC

Manufacturer

GlaxoSmithKline LLC

First approval

2025-12-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown